Scientists from the National Institute of Health and from Celera Genomics Group, a division of PE Corporation, announced that they have a map for the sequencing of the human genome. The decoding involved three billion chemical bases (letters) that make up the human DNA, and allows scientists to find and understand the more than 60,000 human genes. The announced draft allows for the identification of 95% of the genes known to cause disease. This colossal discovery, some argue the most significant ever in human history, has incalculable consequences on the quality of life, and on the longevity of life. The computers are churning to find out what companies will in fact benefit from this discovery, what will be the impact on their revenue and their profits, and ultimately on their market price. Do you know what company to invest in? Do you know what group of companies you should invest in so even if only one of them is a big winner, you will reap huge profits? How much of your investable funds would you put in genome based-companies? The answers may astound you, as will the fact that there is an accessible, easy to understand way for systematically going about answering the above questions to prepare you and your family for a better working life and a better retirement. Time Line: April 2000 Financial industry titan, Julian Robertson of the Tiger Fund calls it quit. Mr. Stanley F. Druckenmiller of the $8.2 billion Quantum Fund, another hedge fund run by the legendary W. Soros, calls it quit. Nicholos Roditi of the London-based Quota Fund, which had lost a third of its value by the end of April 2000, calls it quit. Many others followed suit. All claimed that they could no longer make money for their clients in the ever more unpredictable and gyrating stock market.
Tidak ada komentar:
Posting Komentar